Covid-19 Impact on Paediatric Vaccine Market, Global Research Reports 2020-2021

This report provides a complete quantitative data and qualitative analysis on the global market for Paediatric Vaccine. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Paediatric Vaccine was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Paediatric Vaccine is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Paediatric Vaccine, including the following market information:
Global Paediatric Vaccine Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Paediatric Vaccine Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Paediatric Vaccine Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Paediatric Vaccine Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players
Major competitors identified in this market include GlaxoSmithCline, Merck, Sanofi, Bristol-Myers Squibb, Abbott Laboratories, Eli Lilly, Pfizer, F. Hoffmann-La Roche, Novo Nordisk, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Pneumococcal
Varicella
Combinations
Poliovirus
Hepatitis
MMR
Pediatric Hormones
HIB
Allergy and Respiratory vaccines
Other Pediatric vaccines

Based on the Application:
Age (0-3)
Age (3-12)
Age Above 12